Amplification of IGH/CCND1 fusion gene in a primary plasma cell leukemia case

Cancer Genetics and Cytogenetics
Tomohiro IshigakiShuji Tohda

Abstract

The IGH/CCND1 fusion gene has been reported in many hematologic tumors such as mantle cell lymphoma, chronic lymphocytic leukemia, prolymphocytic leukemia, multiple myeloma, and plasma cell leukemia. We report a case of plasma cell leukemia showing five IGH/CCND1 fusion signals by interphase fluorescence in situ hybridization (FISH). Conventional cytogenetic analysis and multicolor spectral karyotyping showed a complex karyotype that did not include t(11;14). Metaphase FISH studies revealed three IGH/CCND1 fusion signals, two of which were amplified signals. These findings indicate that IGH/CCND1 fusion gene was amplified and interspersed in several chromosomes. The patient was treated with intensive chemotherapy. However, the clinical course was very aggressive. The amplification of the IGH/CCND1 fusion gene may contribute to the aggressive course of the disease. To our knowledge, this is the first case showing amplification of the IGH/CCND1 gene in plasma cell neoplasms.

References

Dec 1, 1994·British Journal of Haematology·M A DimopoulosR Alexanian
Jun 13, 1998·Molecular Pathology : MP·R Donnellan, R Chetty
Jun 10, 2000·British Journal of Haematology·W Hoechtlen-VollmarD Seidel
Oct 29, 2000·British Journal of Haematology·E D RemsteinG W Dewald
Jan 17, 2002·Genes, Chromosomes & Cancer·Alicja M Gruszka-WestwoodDaniel Catovsky
Jan 12, 2005·Cancer Genetics and Cytogenetics·Hong ChangBruce Patterson
Jan 25, 2008·Leukemia·R E TiedemannR Fonseca

❮ Previous
Next ❯

Citations

May 7, 2020·Bioscience Reports·Anum Zehra NaqviMahmood Akhtar Kayani

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.